Identification of risk factors of severe hypersensitivity reactions in general anaesthesia

[1]  E. Jerschow,et al.  Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. , 2014, The Journal of allergy and clinical immunology.

[2]  C. Camargo,et al.  Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. , 2014, The Journal of allergy and clinical immunology.

[3]  A. Sheikh,et al.  International consensus on (ICON) anaphylaxis , 2014, The World Allergy Organization journal.

[4]  L. Borish,et al.  Case fatality and population mortality associated with anaphylaxis in the United States. , 2014, The Journal of allergy and clinical immunology.

[5]  P. Demoly,et al.  Severe drug‐induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010 , 2013, Allergy.

[6]  N. Kounis,et al.  Tryptase levels in coronary syndromes and in hypersensitivity episodes: a common pathway towards Kounis syndrome. , 2011, Atherosclerosis.

[7]  F. Alla,et al.  Anaphylaxis during anesthesia in France: an 8-year national survey. , 2011, The Journal of allergy and clinical immunology.

[8]  P. Demoly,et al.  Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. , 2011, Journal of investigational allergology & clinical immunology.

[9]  T. Volz,et al.  Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly , 2010, Allergy.

[10]  J. Harper,et al.  BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  H. Küchenhoff,et al.  Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. , 2009, The Journal of allergy and clinical immunology.

[12]  U. Müller.  Elevated baseline serum tryptase, mastocytosis and anaphylaxis , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  G. Passalacqua,et al.  Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. , 2009, The Journal of allergy and clinical immunology.

[14]  M. Tang,et al.  Anaphylaxis fatalities and admissions in Australia. , 2009, The Journal of allergy and clinical immunology.

[15]  P. Pemberton,et al.  Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. , 2008, The Journal of allergy and clinical immunology.

[16]  J. Ring,et al.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients , 2008, Allergy.

[17]  P. Correll,et al.  Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. , 2007, The Journal of allergy and clinical immunology.

[18]  M. Dieguez,et al.  Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA) , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  U. Mueller.  Cardiovascular disease and anaphylaxis , 2007, Current opinion in allergy and clinical immunology.

[20]  P. Greenberger,et al.  Fatal anaphylaxis: postmortem findings and associated comorbid diseases. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  B. Mroczko,et al.  Basal serum tryptase level correlates with severity of hymenoptera sting and age. , 2007, Journal of investigational allergology & clinical immunology.

[22]  Sidney C. Smith,et al.  Mast cell tryptase: a new biomarker in patients with stable coronary artery disease. , 2005, Atherosclerosis.

[23]  J. Ring,et al.  Incidence and classification of adverse reactions to plasma substitutes , 1982, Klinische Wochenschrift.

[24]  P. Demoly,et al.  Nomenclature révisée des termes d'allergologie , 2004 .

[25]  R. Pumphrey.  Anaphylaxis: can we tell who is at risk of a fatal reaction? , 2004, Current opinion in allergy and clinical immunology.

[26]  Thomas Bieber,et al.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. , 2004, The Journal of allergy and clinical immunology.

[27]  P. Demoly,et al.  Diagnosis of immediate allergic reactions to beta‐lactam antibiotics , 2003, Allergy.

[28]  F. Alla,et al.  Anaphylactic and Anaphylactoid Reactions Occurring during Anesthesia in France in 1999–2000 , 2003, Anesthesiology.

[29]  J. Bousquet,et al.  A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. , 2001 .

[30]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[31]  H. Sampson,et al.  Fatalities due to anaphylactic reactions to foods. , 2001, The Journal of allergy and clinical immunology.

[32]  Steve L. Taylor,et al.  An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. , 1997, The Journal of allergy and clinical immunology.